β-Endorphin(beta-endorphin) is anendogenousopioidneuropeptideandpeptide hormonethat is produced in certainneuronswithin thecentral nervous systemandperipheral nervous system.[1]It is one of threeendorphinsthat are produced in humans, the others of which includeα-endorphinandγ-endorphin.[2]
| |
| |
| Names | |
|---|---|
| IUPAC name
L-Tyrosylglycylglycyl-L-phenylalanyl-L-methionyl-L-threonyl-L-seryl-L-glutaminyl-L-lysyl-L-seryl-L-glutaminyl-L-threonyl-L-prolyl-L-leucyl-L-valyl-L-threonyl-L-leucyl-L-phenylalanyl-L-lysyl-L-asparaginyl-L-alanyl-L-isoleucyl-L-isoleucyl-L-lysyl-L-asparaginyl-L-alanyl-L-tyrosyl-L-lysyl-L-lysylglycyl-L-glutamine
| |
| Identifiers | |
3D model (JSmol)
|
|
| ChEBI | |
| ChemSpider | |
| ECHA InfoCard | 100.056.646 |
PubChemCID
|
|
| UNII | |
| |
| |
| Properties | |
| C158H251N39O46S | |
| Molar mass | 3465.03g·mol−1 |
Except where otherwise noted, data are given for materials in theirstandard state(at 25 °C [77 °F], 100 kPa).
| |
There are multiple forms of β-endorphins with the full sequence ofTyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu (31 amino acids) denoted as β-endorphin(1-31) and variants truncated to the first 26 and 27 amino acids as β-endorphin(1-26) and β-endorphin(1-27).[1][3][4]However, β-endorphin(1-31) is the only form that possess a potent analgesic effect and it is the primary form located in the anterior pituitary gland, and regions such as the hypothalamus, midbrain, and amygdala.[5]The first 16 amino acids are identical to α-endorphin. β-Endorphin is considered to be a part of theendogenous opioidandendorphinclasses of neuropeptides;[1]all of the established endogenous opioid peptides contain the same N-terminal amino acid sequence, Tyr-Gly-Gly-Phe, followed by either-Metor-Leu.[1]
Function of β-endorphin has been known to be associated withhunger,thrill,pain,maternal care, sexual behavior, andreward cognition.In the broadest sense, β-endorphin is primarily utilized in the body to reduce stress and maintain homeostasis. In behavioral research, studies have shown that β-endorphin is released viavolume transmissioninto theventricular systemin response to a variety of stimuli, andnovel stimuliin particular.[6]
Formation and structure
editβ-Endorphin is found in neurons of thehypothalamus,as well as thepituitarygland. It is derived fromβ-lipotropin,which is produced in thepituitary glandfrom a larger peptide precursor,proopiomelanocortin(POMC).[7]POMC is cleaved into two neuropeptides,adrenocorticotropic hormone(ACTH) and β-lipotropin.[8]The formation of β-endorphin is then the result of cleavage of the C-terminal region of β-lipotropin, producing a 31 amino acid-long neuropeptide with an Alpha -helical secondary structure. However, POMC also gives rise to other peptide hormones, including α- and γ-melanocyte-stimulating hormone(MSH), resulting from intracellular processing by internal enzymes known asprohormone convertases.
A significant factor that differentiates β-endorphin from other endogenous opioids is itshigh affinityfor and lasting effect onμ-opioid receptors.[7]The structure of β-endorphin in part accounts for this through its resistance toproteolytic enzymes,as its secondary structure makes it less vulnerable to degradation.[7]
Function and effects
editβ-Endorphin function is said to be divided into two main categories: local function and global function. Global function of β-endorphin is related to decreasing bodily stress and maintaining homeostasis resulting in pain management, reward effects, and behavioral stability. β-Endorphin in global pathways diffuse to different parts of the body through cerebral spinal fluid in the spinal cord, allowing for β-endorphin release to affect the peripheral nervous system. Localized function of β-endorphin results in release of β-endorphin in different brain regions such as the amygdala or the hypothalamus.[6]The two main methods by which β-endorphin is utilized in the body are peripheral hormonal action[9]and neuroregulation. It is considered to act both as aneurotransmitterand aneuromodulatorsince it produces effects on distant targets that have increased stability and longevity when compared to other neurotransmitters.[5]β-endorphin and otherenkephalinsare often released withACTHto modulate hormone system functioning. Neuroregulation by β-endorphin occurs through interference with the function of another neuropeptide, either by direct inhibition of neuropeptide release or induction of a signaling cascade that reduces a neuropeptide's effects.[8]
Opioid agonist
editβ-Endorphin is an agonist of theopioid receptors;it preferentially binds to theμ-opioid receptor.[1]Evidence suggests that it serves as a primary endogenousligandfor theμ-opioid receptor,[1][10]the same receptor to which the chemicals extracted fromopium,such asmorphine,derive theiranalgesicproperties. β-Endorphin has the highest binding affinity of any endogenous opioid for the μ-opioid receptor.[1][7][10]Opioid receptors are a class ofG-protein coupled receptors,such that when β-endorphin or another opioid binds, a signaling cascade is induced in the cell.[11]Acetylation of the N-terminus of β-endorphin, however, inactivates the neuropeptide, preventing it from binding to its receptor.[7]The opioid receptors are distributed throughout the central nervous system and within the peripheral tissue of neural and non-neural origin. They are also located in high concentrations in theperiaqueductal gray,locus coeruleus,and therostral ventromedial medulla.[12]
Voltage-dependent calcium channels(VDCCs) are important membrane proteins that mediate the depolarization of neurons, and play a major role in promoting the release of neurotransmitters. When endorphin molecules bind to opioid receptors, G proteins activate and dissociate into their constituent Gα and Gβγ sub-units. The Gβγ sub-unit binds to the intracellular loop between the two trans-membrane helices of the VDCC. When the sub-unit binds to the voltage-dependent calcium channel, it produces a voltage-dependent block, which inhibits the channel, preventing the flow of calcium ions into the neuron. Embedded in the cell membrane is also theG protein-coupled inwardly-rectifying potassium channel.When a Gβγ or Gα(GTP) molecule binds to the C-terminus of the potassium channel, it becomes active, and potassium ions are pumped out of the neuron.[13][14]The activation of the potassium channel and subsequent deactivation of the calcium channel causes membranehyperpolarization.This is when there is a change in the membrane's potential, so that it becomes more negative. The reduction in calcium ions causes a reduction of neurotransmitter release because calcium is essential for this event to occur.[15]This means that neurotransmitters such asglutamateandsubstance Pcannot be released from the presynaptic terminal of the neurons. Substance P is a believed to help sensitize postsynaptic neurons to glutamate, aiding in the transmission of pain signals from periphery nerves to the brain.[16]These neurotransmitters are vital in the transmission of pain, and as β-Endorphin reduces the release of these substances, there is a strong analgesic effect.
Pain management
editβ-Endorphin has been primarily studied for its influence onnociception(i.e.,painperception). β-endorphin modulates pain perception both in thecentral nervous systemand theperipheral nervous system.When pain is perceived, pain receptors (nociceptors) send signals to the dorsal horn of thespinal cordand then up to thehypothalamusthrough the release of aneuropeptidecalledsubstance P.[8][6][17][18]In theperipheral nervous system,this signal causes the recruitment ofT-lymphocytes,white blood cells of the immune system, to the area where pain was perceived.[18]T-lymphocytes release β-endorphin in this localized region, allowing it to bind to opioid receptors, causing direct inhibition of substance P.[18][19]In thecentral nervous system,β-endorphin binds to opioid receptors in the dorsal root and inhibits the release of substance P in the spinal cord, reducing the number of excitatory pain signals sent to the brain.[18][17]The hypothalamus responds to the pain signal by releasing β-endorphin through theperiaqueductal greynetwork, which mainly acts to inhibit the release ofGABA,aneurotransmitterwhich prevents the release ofdopamine.[8][17]Thus, the inhibition of GABA release by β-endorphin allows for a greater release of dopamine, in part contributing to the analgesic effect of β-endorphin.[8][17]The combination of these pathways reduces pain sensation, allowing for the body to stop a pain impulse once it has been sent.
β-Endorphin has approximately 18 to 33 times the analgesic potency ofmorphine,[20]though its hormonal effect is species dependent.[9]
Exercise
editβ-Endorphin release in response to exercise has been known and studied since at least the 1980s.[21]Studies have demonstrated that serum concentrations of endogenous opioids, in particular β-endorphin andβ-lipotropin,increase in response to both acute exercise and training.[21]The release of β-endorphin during exercise is associated with a phenomenon colloquially known in popular culture as arunner's high.[22]
Sunlight
editThere is evidence that β-endorphin is released in response toultraviolet radiation,either through sun exposure or artificial tanning.[23]This is thought to contribute toaddiction behavioramong excessivesunbathersand users ofartificial tanningdespite health risks.
Addiction
editStudies suggest that β-Endorphins could be correlated withalcohol addictiondue to their involvement with the brain'smesolimbic reward system.[24]Alcohol consumption causes an increase in the release of β-Endorphins within the regions of the brain's reward system. Regular and long-term consumption of alcohol consequently leads to a deficit in the levels of β-Endorphins that requires continuous consumption of alcohol to replenish. Individuals with a deficiency of β-Endorphins due to genetics may be more vulnerable to alcohol addiction as a result.[25]
Mechanism of action
editβ-Endorphin acts as an agonist that binds to various types ofG protein–coupled receptors(GPCRs), most notably to the mu, delta, and kappa opioid receptors. Binding to these receptors prevents the release of Substance P in the case of theperipheral nervous system,and the inhibitory neurotransmitter, GABA, in thecentral nervous system[26]The receptors are responsible for supra-spinal analgesia.[medical citation needed]
History
editβ-Endorphin was discovered in camel pituitary extracts by C.H. Li and David Chung.[27]The primary structure of β-endorphin was unknowingly determined 10 years earlier, when Li and colleagues analyzed the sequence of another neuropeptide produced in the pituitary gland,γ-lipotropin.They noticed that the C-terminus region of this neuropeptide was similar to that of someenkephalins,suggesting that it may have a similar function to these neuropeptides. The C-terminal sequence of γ-lipotropin turned out to be the primary sequence of the β-endorphin.[7]
References
edit- ^abcdefgMalenka RC, Nestler EJ, Hyman SE (2009). "Chapter 7: Neuropeptides". In Sydor A, Brown RY (eds.).Molecular Neuropharmacology: A Foundation for Clinical Neuroscience(2nd ed.). New York: McGraw-Hill Medical. pp. 184, 190, 192.ISBN978-0-07-148127-4.
Opioid Peptides
β-Endorphin (also a pituitary hormone)...
Opioid peptides are encoded by three distinct genes. These precursors include POMC, from which the opioid peptide β-endorphin and several nonopioid peptides are derived, as discussed earlier; proenkephalin, from which met-enkephalin and leu-enkephalin are derived; and prodynorphin, which is the precursor of dynorphin and related peptides. Although they come from different precursors, opioid peptides share significant amino acid sequence identity. Specifically, all of the well-validated endogenous opioids contain the same four N-terminal amino acids (Tyr-Gly-Gly-Phe), followed by either Met or Leu... Among endogenous opioid peptides, β-endorphin binds preferentially to μ receptors.... Shared opioid peptide sequences. Although they vary in length from as few as five amino acids (enkephalins) to as many as 31 (β-endorphin), the endogenous opioid peptides shown here contain a shared N-terminal sequence followed by either Met or Leu. - ^Li Y, Lefever MR, Muthu D, Bidlack JM, Bilsky EJ, Polt R (February 2012)."Opioid glycopeptide analgesics derived from endogenous enkephalins and endorphins".Future Medicinal Chemistry.4(2).Table 1: Endogenous opioid peptides.doi:10.4155/fmc.11.195.PMC3306179.PMID22300099.
- ^Pilozzi A, Carro C, Huang X (December 2020)."Roles of β-Endorphin in Stress, Behavior, Neuroinflammation, and Brain Energy Metabolism".International Journal of Molecular Sciences.22(1): 338.doi:10.3390/ijms22010338.PMC7796446.PMID33396962.
- ^DBGET
- ^abPilozzi A, Carro C, Huang X (30 December 2020)."Roles of β-endorphin in stress, behavior, neuroinflammation, and brain energy metabolism".International Journal of Molecular Sciences.22(1): 338.doi:10.3390/ijms22010338.PMC7796446.PMID33396962.
- ^abcVeening JG, Barendregt HP (January 2015)."The effects of beta-endorphin: state change modification".Fluids and Barriers of the CNS.12:3.doi:10.1186/2045-8118-12-3.PMC4429837.PMID25879522.
- ^abcdefSmyth DG (May 2016)."60 YEARS OF POMC: Lipotropin and beta-endorphin: a perspective".Journal of Molecular Endocrinology.56(4): T13-25.doi:10.1530/JME-16-0033.PMID26903509.
- ^abcdeDalayeun JF, Norès JM, Bergal S (1993). "Physiology of beta-endorphins. A close-up view and a review of the literature".Biomedicine & Pharmacotherapy.47(8): 311–20.doi:10.1016/0753-3322(93)90080-5.PMID7520295.
- ^abFoley KM, Kourides IA, Inturrisi CE, Kaiko RF, Zaroulis CG, Posner JB, Houde RW, Li CH (October 1979)."beta-Endorphin: analgesic and hormonal effects in humans".Proceedings of the National Academy of Sciences of the United States of America.76(10): 5377–81.Bibcode:1979PNAS...76.5377F.doi:10.1073/pnas.76.10.5377.PMC413146.PMID291954.
- ^abBorsodi A, Caló G, Chavkin C, Christie MJ, Civelli O, Cox BM, Devi LA, Evans C, Henderson G, Höllt V, Kieffer B, Kitchen I, Kreek MJ, Liu-Chen LY, Meunier JC, Portoghese PS, Shippenberg TS, Simon EJ, Toll L, Traynor JR, Ueda H, Wong YH (15 March 2017)."Opioid receptors: μ receptor".IUPHAR/BPS Guide to Pharmacology.International Union of Basic and Clinical Pharmacology.Retrieved26 May2017.
Principal endogenous agonists (Human)
β-endorphin (POMC, P01189), [Met]enkephalin (PENK, P01210), [Leu]enkephalin (PENK, P01210)...
Comments: β-Endorphin is the highest potency endogenous ligand - ^Livingston KE, Traynor JR (2018)."Allostery at opioid receptors: modulation with small molecule ligands".British Journal of Pharmacology.175(14): 2846–2856.doi:10.1111/bph.13823.PMC6016636.PMID28419415.
- ^Al-Hasani R, Bruchas MR (December 2011)."Molecular mechanisms of opioid receptor-dependent signaling and behavior".Anesthesiology.115(6): 1363–81.doi:10.1097/ALN.0b013e318238bba6.PMC3698859.PMID22020140.
- ^Yamada M, Inanobe A, Kurachi Y (December 1998)."G protein regulation of potassium ion channels".Pharmacological Reviews.50(4): 723–60.PMID9860808.
- ^Reuveny E, Slesinger PA, Inglese J, Morales JM, Iñiguez-Liuhi JA, Lefkowitz RJ, Bourne HR, Jan YN, Jan LY (July 1994). "Activation of the Cloned Muscarinic Potassium Channel by G Protein βγ Subunits".Nature.370(6485): 143–146.Bibcode:1994Natur.370..143R.doi:10.1038/370143a0.PMID8022483.S2CID4345632.
- ^Kosten TR, George TP (July 2002)."The neurobiology of opioid dependence: implications for treatment".Science & Practice Perspectives.1(1): 13–20.doi:10.1151/spp021113(inactive 10 November 2024).PMC2851054.PMID18567959.
{{cite journal}}:CS1 maint: DOI inactive as of November 2024 (link) - ^Chaudrhy S, Gossman W (2024)."Biochemistry, Endorphins".National Institute of Health.StatPearls.PMID29262177.Retrieved10 November2024.
- ^abcdSprouse-Blum AS, Smith G, Sugai D, Parsa FD (March 2010)."Understanding endorphins and their importance in pain management".Hawaii Medical Journal.69(3): 70–1.PMC3104618.PMID20397507.
- ^abcdLuan YH, Wang D, Yu Q, Chai XQ (February 2017). "Action of β-endorphin and nonsteroidal anti-inflammatory drugs, and the possible effects of nonsteroidal anti-inflammatory drugs on β-endorphin".Journal of Clinical Anesthesia.37:123–128.doi:10.1016/j.jclinane.2016.12.016.PMID28235500.
- ^Plein LM, Rittner HL (2018)."Opioids and the immune system – friend or foe".British Journal of Pharmacology.175(14): 2717–2725.doi:10.1111/bph.13750.PMC6016673.PMID28213891.
- ^Loh HH,Tseng LF, Wei E, Li CH (August 1976)."beta-endorphin is a potent analgesic agent".Proceedings of the National Academy of Sciences of the United States of America.73(8): 2895–8.Bibcode:1976PNAS...73.2895L.doi:10.1073/pnas.73.8.2895.PMC430793.PMID8780.
- ^abHarber VJ, Sutton JR (March–April 1984). "Endorphins and exercise".Sports Medicine.1(2): 154–71.doi:10.2165/00007256-198401020-00004.PMID6091217.S2CID6435497.
- ^Goldberg J (19 February 2014)."Exercise and Depression".WebMD.Retrieved14 July2014.
- ^"Addicted to the Sun".hms.harvard.edu.19 June 2014.Retrieved29 August2023.
- ^Zalewska-Kaszubska J, Czarnecka E (April 2005)."Deficit in beta-endorphin peptide and tendency to alcohol abuse".Peptides.26(4): 702.doi:10.1016/j.peptides.2004.11.010.PMID15752586.Retrieved26 October2024.
- ^Zalewska-Kaszubska J, Czarnecka E (April 2005)."Deficit in beta-endorphin peptide and tendency to alcohol abuse".Peptides.26(4): 701–705.doi:10.1016/j.peptides.2004.11.010.PMID15752586.Retrieved26 October2024.
- ^Graefe BS, Rahimi N, Shamim SM (2024)."Biochemistry, Substance P".National Institute of Health.StatPearls.PMID32119470.Retrieved10 November2024.
- ^Li CH, Chung D (April 1976)."Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands".Proceedings of the National Academy of Sciences of the United States of America.73(4): 1145–8.Bibcode:1976PNAS...73.1145L.doi:10.1073/pnas.73.4.1145.PMC430217.PMID1063395.
External links
edit- CID 16132316fromPubChem– β-endorphin
- CID 3081525fromPubChem– β-endorphin (1-9)
- CID 133304fromPubChem– β-endorphin (2-9)
- β-endorphinat the U.S. National Library of MedicineMedical Subject Headings(MeSH)